December 2024

Data showcased at SABCS and ASH reflect progress and growth of Jazz’s research and development in oncology and demonstrate ongoing efforts to redefine what is possible for cancer treatment DUBLIN, Dec. 3, 2024 /PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that th

Company to Transform Everyday Life with Personalized, AI-Powered Experiences SEOUL, South Korea, Dec. 3, 2024 /CNW/ – LG Electronics (LG) invites consumers worldwide to join the LG World Premiere press conference, starting at 08:00 (PST) on January 6 at the Mandalay Bay Convention Center in

Agreement demonstrates the expanding leadership of Accord BioPharma and Intas in the biosimilar market RALEIGH, N.C., Dec. 3, 2024 /PRNewswire/ — Accord BioPharma, Inc., the U.S. specialty division of Intas Pharmaceuticals, Ltd. (“Intas Pharmaceuticals”), focused on the development

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: